Additionally, patients administered L-carnitine had a lower incidence of severe heart failure, left ventricular hypertrophy, arrhythmias, and total cardiac events, including mortality and nonfatal myocardial infarctions, compared to those receiving placebo (Singh et al
Eleven students were excluded from the study because their hematological analyses were outside the reference range
Clinically, the ATTAIN Phase 3 program showed that orforglipron at its highest dose delivered a mean weight loss of 12.4% over 72 weeks, slightly less than the WEGOVY pills 13.6% at 64 weeks, but with a broader, more diverse patient population of over 3,000 participants
Fortunately, the medical industry is catching up
It is the slot most consistently kept even in a once-daily schedule
Biocon Teva Pharmaceutical Industries Ltd